The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated - PubMed (original) (raw)

The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated

J Sample et al. J Virol. 1992 Aug.

Abstract

The only member of the Epstein-Barr virus family of nuclear proteins (EBNAs) expressed during type I and type II latent infections is EBNA-1. This is in contrast to type III latency, during which all six nuclear proteins are expressed from a common transcription unit. The exclusive expression of EBNA-1 during type I and II latency is mediated through a recently identified promoter, Fp. The objective of this study was to characterize Fp in the Burkitt lymphoma cell background, where it is known to be differentially utilized. Using a short-term transfection assay and reporter gene plasmids containing Fp linked to the human growth hormone, we examined Fp activity in type I and type III latently infected and virus-negative Burkitt lymphoma cells. The data suggested that Fp is predominantly regulated through two distinct elements located between +24 and +270 relative to the transcription start site. One element positively mediates Fp activity, probably at the level of transcription, and acts in a virus-independent manner. The second element contains the EBNA-1 DNA binding domain III and negatively regulates Fp-directed gene expression in trans with EBNA-1 in type III as well as type I latency. Thus, we have identified a third function of EBNA-1, i.e., that of a repressor of gene expression, in addition to its known role in viral DNA replication and its ability to trans-activate gene expression. The overall activity of Fp in type I latently infected Burkitt cells was approximately sixfold lower than in virus-negative Burkitt cells, in which there is no autoregulation, suggesting that there is a fine balance between these two opposing regulatory elements during type I latency.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Virol. 1979 Oct;32(1):8-18 - PubMed
    1. Nucleic Acids Res. 1991 May 11;19(9):2435-40 - PubMed
    1. J Virol. 1992 Feb;66(2):706-14 - PubMed
    1. J Virol. 1991 Nov;65(11):6252-9 - PubMed
    1. J Virol. 1991 Jan;65(1):483-8 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources